Pharma news, pharmaceutical news, Pharma Industry News, India Pharmaceutical Industry

SMS BOS < space > stock query at 56388
LYONDELLBASELL UNDER CHAPTER 11 BANKRUPTCY PROTECTION SINCE JAN-2009
LYONDELLBASELL IS ONE OF THE WORLD'S LARGEST PETROCHEMICALS COMPANY
RIL MAKES NON-BINDING CASH OFFER TO BUY CONTROL IN LYONDELLBASELL
OFFER APART FROM EQUITY FINANCING PROPOSED BY RIL FOR LYONDELLBASELL
OFFER UPON EMERGENCE OF LB FROM CHAPTER-11
OFFER SUBJECT TO DUE DILIGENCE & SUFFICIENT CREDITOR SUPPORT
LYONDELLBASELL: RIL OFFER POTENTIAL ALTERNATIVE TO REORGANIZATION PLAN
LYONDELLBASELL: TO TRY TO MAXIMIZE VALUE FOR ALL CREDITORS
LYONDELLBASELL PRIVATELY OWNED BY PROCHEMIE GMBH
RIL: NO ASSURANCE THAT OPPORTUNITIES WILL RESULT IN A TRANSACTION
RIL: REVIEWING OTHER GROWTH OPPORTUNITIES FOR GROWTH IN CORE BIZ
SUBMITTED TO LYONDELLBASELL NON BIDDING OFFER TO ACQUIRE FOR CASH
CASH OFFER FOR A CONTROLLING STAKE UPON EMERGENCE FROM CHAPTER 11
OFFER PURSUANT TO ITS PLAN OF REORGANISATION
OFFER IS PRELIMINARY AND SUBJECT TO CUSTOMARY CONDITIONS
RIL REVIEWING OTHER GROWTH OPPORTUNITIES FOR GROWTH
Stock moves on WAP: Logon to mobile.ndtv.com on GPRS browser
SMS INDEX to 56388 for live market updates
Finance buzz: Logon to mobile.ndtv.com on GPRS browsers
Stock updates: SMS STO followed by scrip name to 56388
For Kingfisher Airlines flight updates sms KING to 56388
Email us at buyorsell@ndtv.com
Call us at 011-26201171
DELL LOST 10% ON FRIDAY AFTER MISSING REVENUES & EARNINGS TARGET FOR Q3
GOLDMAN SACHS DOWN 1.6%, GE DOWN 1.1%, CISCO DOWN 1%, MERCK UP 3.2%
DOW JONES FALLS FOR 3RD STRAIGHT DAY TO END LOWER BY 0.1% ON FRIDAY
DELL LOST 10% ON FRIDAY AFTER MISSING REVENUES & EARNINGS TARGET FOR Q2
U.S MARKETS ENDED LOWER ON FRIDAY AS TECH STOCKS TOOK THE BIGGEST HIT
NASDAQ DOWN 0.5%, S&P 500 INDEX LOWER BY 0.3% AT CLOSE ON FRIDAY

Updated: 20/11/09 | 08:57 PM IST

Pharma

Wockhardt and DBS may opt for out-of-court settlement

It seems like the legal battle between Wockhardt and Singapore-based DBS, a creditor of Wockhardt, to ease out soon.

Comments: Read (0) Post

Cipla launches drug to treat Swine flu virus

Drugmaker Cipla on Wednesday launched its generic version of Roche's Tamiflu, used in the treatment of the H1N1 swine flu virus. The drug has been cleared by the WHO cleared and it will now be available in select drug stores in India.

Comments: Read (0) Post

Daiichi to launch Ranbaxy drugs in Japan soon

Daiichi Sankyo, which has a majority stake in Ranbaxy Laboratories, today said it is going to launch some of Ranbaxy's generic medicine in the Japanese market soon.

Comments: Read (0) Post

Cipla Q2 net profit jumps 82% to Rs 275.74 cr

Pharma major Cipla Ltd on Wednesday said its net profit rose by 82.08 per cent to Rs 275.74 crore for the second quarter ended September 30, 2009, over the same period last fiscal.

Comments: Read (0) Post

Sun Pharma Q2 profit dips 11% to Rs 453.8 cr

The country's most valued drug maker Sun Pharmaceutical Industries on Wednesday reported a decline of 11 per cent in its consolidated net profit to Rs 453.81 crore for the second quarter of the current fiscal.

Comments: Read (0) Post

No intention of buying Ranbaxy: Pfizer

The Lipitor deal had further added to the speculation of Pfizer picking up a stake in Ranbaxy. But Pfizer on Wednesday told NDTV that it has no intention of picking up stake in Ranbaxy.

Comments: Read (0) Post

Special

'India will be among top three economies by 2050'

India will be the third largest economy in the world after China and United States by 2050, a US-based internationally recognised foreign-policy think tank has said. It also said China will become the world’s largest economy in 2032.

More: Mukesh Ambani richest Indian in Forbes list | Five pairs of siblings in Forbes India richest list | Billionaires' wealth surge outpaces economic revival | Six women in the Forbes India rich list

Market Watch

Graphs

Stocks